Immune cell therapy for melanoma with liver spread
Treatments studied
Part of Cancer, Eyes & vision, Skin clinical trials.
This study uses your own immune cells (called TILs) to fight melanoma that has spread to the liver. Doctors will remove a piece of the tumor, grow the immune cells in a lab, and give them back to you to help shrink the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have melanoma that has spread to the liver, either from the eye or skin.
- For skin melanoma, you must have already tried at least one prior treatment, such as immunotherapy.
- You must have a liver tumor that can be removed by surgery to collect immune cells.
- You need to be in generally good physical condition to participate.
- You cannot have serious kidney, liver, or blood problems, or other active infections or autoimmune diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using your own immune cells to fight advanced melanoma. The cells are taken from a tumor, grown in a lab, and given back to you either near the tumor or throughout your body.
This trial tests whether adding a liver-directed therapy (PHP) to a combination of two immunotherapy drugs (ipilimumab and nivolumab) works better than the immunotherapy drugs alone for people whose uveal melanoma has spread to the liver.
This trial tests using your own immune cells (TILs) to fight advanced uveal melanoma, undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, or angiosarcoma. It aims to see if this treatment can shrink tumors or slow their growth.
This study tests how well the liver responds to a treatment called percutaneous hepatic perfusion with melphalan (chemotherapy delivered directly to the liver) in people with uveal melanoma that has spread to the liver. The goal is to see how the immune system reacts and if the treatment helps control the disease.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This study tests a new type of cell therapy made from your own immune cells (called TILs) to see if it can shrink tumors better than standard chemotherapy in people with advanced melanoma that has stopped responding to immunotherapy. If you qualify, you may have a chance to try a personalized treatment that uses your body's own defenses to fight the cancer.
Hear when a new Uveal Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.